Monkeypox expands its presence in Canada: Can it affect stock markets?

June 07, 2022 11:12 PM AEST | By Raza Naqvi
 Monkeypox expands its presence in Canada: Can it affect stock markets?
Image source: © Angellodeco | Megapixl.com

Highlights

  • According to the BC Centre for Disease Control, the Monkeypox infection was confirmed by laboratory tests.
  • As per the Government of Canada, the Public Health Agency is actively monitoring the situation.
  • The virus that causes Monkeypox is diagnosed at Canada's National Microbiology Laboratory.

A patient in Vancouver was reportedly diagnosed with Monkeypox on June 6, which is the first incident in British Columbia. According to the BC Centre for Disease Control, the infection was confirmed by laboratory tests, which is waiting for National Microbiology Laboratory's confirmation.

Also Read: Tonix (TNXP) stock soars after monkeypox-related patent. Buy call?

According to reports, Vancouver Coastal Health is performing a public health follow-up, although the danger to the public remains low.

Meanwhile, the data by the Government of Canada suggests that there were 77 confirmed cases across Canada as of June 3. Some published reports indicate that Monkeypox cases in Canada began through a sauna in Montreal.

Over 700 cases of Monkeypox have been reportedly discovered in non-endemic countries, particularly in Europe, since May.

What is Monkeypox?

Monkeypox is transmitted through animals, and its symptoms are like smallpox. However, it is less severe, says the World Health Organization.

Canada Monkeypox

The disease can spread through infected surfaces such as towels and bedding. Also, it can be transmitted from one person to another via body fluids, among others.

The common symptoms of Monkeypox include fever and rash. A delay in detecting the disease can lead to several medical issues.

How is Canada handling Monkeypox?

As per the Government of Canada, the Public Health Agency actively monitors the situation in collaboration with provinces and territories, apart from international partners. The focus is on preventing it from spreading further.

Also, the Chief Public Health Officer and Chief Medical Officers of Health are working in sync to ensure that Monkeypox cases are quickly detected and managed to protect Canadians' health.

The virus that causes Monkeypox is being diagnosed at Canada's National Microbiology Laboratory. In addition, the lab is performing whole-genome sequencing, which is a type of advanced fingerprint analysis, on monkeypox samples from Canada.

Also, to provide testing advice and increase Monkeypox testing capability, the laboratory collaborates closely with provincial and territorial public health laboratories.

Bottom line

It seems highly unlikely that the rise in Monkeypox cases will majorly impact the stock market, as some scientists believe that it won't be the next global pandemic.

The issues like record-high inflation and rising interest rates are already contributing to the volatility in the equities markets. Also, others macroeconomic factors like the war between Russia and Ukraine continue to affect the needs and the global economy.

On June 6, the Canadian markets remained almost unchanged as the S&P/TSX Composite Index only recorded a growth of 0.1 per cent and closed at 20,819.09 points.

Also Read: Monkeypox spreads in Canada: 5 vaccine stocks to keep on your radar


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.